Response to "Weight-loss drugs like Wegovy could lead to an increased risk of fragility fractures in population at risk".

Authors

Kushner, Robert F; Ryan, Donna H; Harder-Lauridsen, Nina M; Jeppesen, Ole Kleist; Kallenbach, Klaus; Lincoff, A Michael; Lingvay, Ildiko